These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Acutely psychotic patients: a treatment approach. Wagemaker H; Lippmann S; Cade JR South Med J; 1985 Jul; 78(7):833-7. PubMed ID: 2861662 [TBL] [Abstract][Full Text] [Related]
25. [The customary drugs in the therapy of mental illness in France]. Ginestet D; Deniker P Nervenarzt; 1967 Sep; 38(9):400-3. PubMed ID: 6052766 [No Abstract] [Full Text] [Related]
26. Familial differences in lithium responsive versus lithium nonresponsive psychoses. Sautter F; Garver D J Psychiatr Res; 1985; 19(1):1-8. PubMed ID: 3989734 [TBL] [Abstract][Full Text] [Related]
27. [The lithium concentration of the blood plasma in combined therapy with lithium carbonate and carbamazepine]. Skorik AI Farmakol Toksikol; 1991; 54(4):57-9. PubMed ID: 1786831 [TBL] [Abstract][Full Text] [Related]
28. Treatment of depression in bipolar disorder: new directions for research. Zornberg GL; Pope HG J Clin Psychopharmacol; 1993 Dec; 13(6):397-408. PubMed ID: 8120153 [TBL] [Abstract][Full Text] [Related]
29. Biological relationships between mania and melancholia. Post RM; Uhde TW Encephale; 1982; 8(2):213-28. PubMed ID: 6179764 [TBL] [Abstract][Full Text] [Related]
30. Drug treatment of schizophrenia. Hollister LE Psychiatr Clin North Am; 1984 Sep; 7(3):435-52. PubMed ID: 6148741 [TBL] [Abstract][Full Text] [Related]
32. [Complications of combined use of lithium salts and neuroleptics in patients with endogenous psychoses]. Mosolov SN Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):115-21. PubMed ID: 6134409 [TBL] [Abstract][Full Text] [Related]
33. Recent advances in the drug treatment of the functional psychoses. Bennie FH Scott Med J; 1976 Apr; 21(2):79-82. PubMed ID: 941003 [TBL] [Abstract][Full Text] [Related]
34. Biology of psychoses: past research and new frontiers. Brodie HK South Med J; 1977 Sep; 70(9):1064-6. PubMed ID: 331484 [TBL] [Abstract][Full Text] [Related]
35. [Lithium in erythrocytes--model value and clinical relevance]. Peker J; Adam W; Quasdorf G Psychiatr Neurol Med Psychol (Leipz); 1984 Jan; 36(1):12-7. PubMed ID: 6709762 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of lithium response in bipolar disorder. Alda M J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559 [TBL] [Abstract][Full Text] [Related]
37. [Schizophrenia and treatment with lithium salts. Current data from the literature]. Matot JP; Olié JP; Lôo H Encephale; 1983; 9(1):49-57. PubMed ID: 6872934 [TBL] [Abstract][Full Text] [Related]
38. [The basic criteria for clinical evaluation of the effect of tranquilizers]. Aleksandrovskiĭ IuA Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1873-82. PubMed ID: 5511527 [No Abstract] [Full Text] [Related]
39. [Comparative evaluation of clinical and economic effectiveness of preventive therapy of affective and schizoaffective psychoses]. Ushakov IuV; Kostiukova EG; Kalugina LI; Mirzoian MG Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):79-82. PubMed ID: 2176049 [TBL] [Abstract][Full Text] [Related]
40. Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder. Dean B; Digney A; Sundram S; Thomas E; Scarr E Psychiatry Res; 2008 Feb; 158(1):75-8. PubMed ID: 18096247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]